Igc PharmaIGC
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 30 institutions reported holding Igc Pharma Inc. (IGC) in their 13F filings, down 5 from Q3 2025. 3 opened new positions and 9 sold out. The largest holders were Vanguard Group Inc. ($323K), Renaissance Technologies ($259K) and Geode Capital Management, LLC ($242K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Ken Fisher (0.0% of Fisher Asset Management's portfolio).
- Company
- Igc Pharma Inc.
- CUSIP
- 45408X308
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $60 |
| Exits | 9 | $96K |
All 13F filers, Q3 2025 → Q4 2025: 211,257 shares bought and 895,860 shares sold, net −684,603 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Vanguard Group Inc. | 0.00% | No change | 1,149,268 | $323K |
| Renaissance Technologies | 0.00% | Reduce -24.6% | 919,641 | $259K |
| Geode Capital Management, LLC | 0.00% | Add +0.9% | 860,477 | $242K |
| BlackRock, Inc. | 0.00% | No change | 703,798 | $198K |
| Citadel Advisors | 0.00% | Reduce -55.8% | 277,594 | $78K |
| State Street Corp. | 0.00% | Add +25.3% | 200,799 | $57K |
| Susquehanna International Group, LLP | 0.00% | Add +1009.9% | 154,959 | $44K |
| Northern Trust Corp. | 0.00% | No change | 113,407 | $32K |
| Dearborn Partners LLC | 0.00% | No change | 84,401 | $24K |
| Lawood & Co. | 0.02% | — | 75,000 | $21K |
| Goldman Sachs Group Inc. | 0.00% | No change | 65,541 | $18K |
| Fisher Asset Management | 0.00% | No change | 43,400 | $12K |
| Truist Financial Corp. | 0.00% | No change | 36,667 | $10K |
| Commonwealth Equity Services, LLC | 0.00% | Reduce -4.6% | 33,348 | $9K |
| XTX Topco Ltd | 0.00% | Reduce -16.7% | 28,324 | $8K |
| T3 Companies, LLC | 0.01% | — | 20,000 | $6K |
| UBS Group AG | 0.00% | Add +552.5% | 19,869 | $6K |
| Morgan Stanley | 0.00% | No change | 17,707 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +47.0% | 14,392 | $4K |
| Group One Trading LLC | 0.00% | No change | 7,187 | $2K |
| Geneos Wealth Management Inc. | 0.00% | No change | 3,000 | $840 |
| Bank of America Corp. | 0.00% | Reduce -54.3% | 1,808 | $508 |
| CIBC Private Wealth Group LLC | 0.00% | No change | 655 | $184 |
| Caitlin John, LLC | 0.00% | No change | 200 | $56 |
| Jones Financial Companies LLLP | 0.00% | New | 110 | $31 |
| Hurley Capital, LLC | 0.00% | No change | 100 | $28 |
| Root Financial Partners, LLC | 0.00% | New | 100 | $28 |
| Farther Finance Advisors, LLC | 0.00% | No change | 100 | $28 |
| DHJJ Financial Advisors, Ltd. | 0.00% | No change | 80 | $23 |
| Triumph Capital Management | 0.00% | New | 2 | $1 |
"% of holder's portfolio" is IGC's weight in each manager's 13F, not the share of Igc Pharma Inc. the manager owns.